# ClinicalTrials.gov record NCT05882045

> PeptideScanner retained ClinicalTrials.gov record NCT05882045 at 2026-08-10T18:10:03.944Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide.

- Evidence object: `story:clinicaltrials-gov-nct05882045-retatrutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-30
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05882045-retatrutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05882045-retatrutide-v1.json
- Content SHA-256: `953ee69a382f4a203a4b764ac53a5b667e37803fcdd78abca4c5179a069214d1`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05882045 ([`ctg-observation-nct05882045-2026-07-30-d21e38ddcccc`](#source-ctg-observation-nct05882045-2026-07-30-d21e38ddcccc))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05882045 at 2026-08-10T18:10:03.944Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide. ([`ctg-observation-nct05882045-2026-07-30-d21e38ddcccc`](#source-ctg-observation-nct05882045-2026-07-30-d21e38ddcccc))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05882045 at 2026-08-10T18:10:03.944Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide. ([`ctg-observation-nct05882045-2026-07-30-d21e38ddcccc`](#source-ctg-observation-nct05882045-2026-07-30-d21e38ddcccc))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05882045-2026-07-30-d21e38ddcccc`](#source-ctg-observation-nct05882045-2026-07-30-d21e38ddcccc))

## Sources

<a id="source-ctg-observation-nct05882045-2026-07-30-d21e38ddcccc"></a>
- **ClinicalTrials.gov record NCT05882045 · retained source version 2026-07-30:d21e38ddcccc7ab66ec1bddaa910bf3c7a7a3149a43f4ac27918a9e80f8452da** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05882045) (`ctg-observation-nct05882045-2026-07-30-d21e38ddcccc`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05882045." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05882045-retatrutide-v1.json SHA-256: 953ee69a382f4a203a4b764ac53a5b667e37803fcdd78abca4c5179a069214d1.